Intercell

closed

Intercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious.

Launch date

Jan 1998

Market cap

Enterprise valuation

Company register number MI1164292

Vienna Austria (HQ)

Date	Investors	Amount	Round
Aug 1998	Techno Venture Management	N/A	Series A
Jan 2001	N/A	N/A	Series B
Jul 2003*	Apax Partners Star Ventures Global Life Science Ventures MPM BioImpact Techno Venture Management	$50.0m	Series C
Feb 2005	N/A	N/A	IPO
Dec 2007	Thuja Capital	N/A	Post IPO Equity
Total Funding		CAD68.2m

ACQUISITION by Intercell May 2008

Recent News about Intercell